Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
by ruth on February 7, 2006
CSL is confident that there is room for them in the marketplace, considering that the other big pharma companies such as Sanofi pasteur, GlaxoSmithKline and Chiron are revving up their productions. MedImmune even had a nasal spray version of the flu vaccine developed.
McNamee [CSL's chief executive said] said CSL provides geographical and seasonal diversity as a supplier - Australia's flu season peaks in July and August, compared with January and February for the U.S. - which gives the company leverage when another manufacturer experiences production problems.
CSL also is testing a prototype for a bird flu vaccine that could be ready within two years.
The public can just benefit from more companies producing flu vaccines (or any other product for that matter), right?
Read full story from SeattlePI.com.
Permalink: CSL Limited Enters Flu Vaccine Market
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/15114
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for CSL Limited Enters Flu Vaccine Market:
|
Rating: 6.00 out of 4 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
